-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Aqtm4ySK7nSNMNwXFTmhqdvy1x49arzyRa13ckPxPyQT+eKLiSM/Bjg8Y5/hG6hs uxvZkIwl7et0c08p09/KyQ== 9999999997-09-001137.txt : 20090112 9999999997-09-001137.hdr.sgml : 20090112 20090112154843 ACCESSION NUMBER: 9999999997-09-001137 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20090112 DATE AS OF CHANGE: 20090112 20090112 20090112 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CELL THERAPEUTICS INC CENTRAL INDEX KEY: 0000891293 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 911533912 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 001-12465 FILM NUMBER: 09521716 BUSINESS ADDRESS: STREET 1: 501 ELLIOTT AVE W STREET 2: STE 400 CITY: SEATTLE STATE: WA ZIP: 98119 BUSINESS PHONE: 2062707100 MAIL ADDRESS: STREET 1: 501 ELLIOTT AVE W STREET 2: STE 400 CITY: SEATTLE STATE: WA ZIP: 98119 CT ORDER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C0-)>+CS],-"C0V(#`@;V)J#3P\+TQI;F5A-IB M8&#@9&!@?L(`!&*K&%`!$Q"S,'`<8%!`$N2$8@8&908>7L8^!E8_2:DDWH0+ M3`M@FF2W035;`3$C`X-4'X1FUH";PL;`H*<`$67D!P@P`%K_"(X-"F5N9'-T M%LW(#,Y72]$96-O9&5087)MX`>`T*96YD6]U="]/;F5#;VQU;6XO4W1R=6-T5')E95)O;W0@-R`P M(%(O5'EP92]#871A;&]G+TQA;F%LP(#`@-C$R(#'1=+T5X=$=3=&%T93P\+T=3,"`U-B`P(%(^/CX^ M+U1Y<&4O4&%G93X^#65N9&]B:@TT.2`P(&]B:@T\/"]3=6)T>7!E+U1R=654 M>7!E+T9O;G1$97-C7!E+T9O;G0^/@UE;F1O M8FH--3`@,"!O8FH-6R])0T-"87-E9"`U,R`P(%)=#65N9&]B:@TU,2`P(&]B M:@T\/"],96YG=&@@,3,R,B]&:6QT97(O1FQA=&5$96-O9&4^/G-TON%)?H#*$X9O5:B4'VUEO&Z>RB51I4U48QO%4!+Q\;#;_ MOG=FP.`$-UW[`69@SIQ[[KEWN(XF5W_`QX]7M^%J#@9\^G0]#V%R%6X-2"J< MX'^HDGQR=8-3C]7D*HH,(!#M)\043_%B&2YXAJ_[-D1/$P74Z)_)XI;C]-BD MPS9`(SIQ()I?>-/LWHQ^O?"&U;VA&;IA$!^B!+J[9]`L/?"=;I=T\E6Y7Z^B MA:HYRARVJN8JT2SBH\46U+^B+V_@[3-XC*V%YW<([^J>/T3?+L+[S2I:<62$ MG*WG@)O9RI_AY]GZ1MQ">'=[N]IN5W?K\2V=\RW):4O"M_1T0OH=E2]QWL3E M"RH_!=,P@E&-W%YOCB68$UNW[($RX^IZYUR"$Y>`@SAZX`ZCO]O,%QNX435? MV.QF+KKO,HR9Q)]7D"7$\@UI%D&T8&6L>HJ1]K4+*FFL,H3U59TE2CC]`AYR\_6??== M=J>20O,:`R+*DF44UH4.!`6U78P3PN4OIF5@0*-(5A^G%PR`_A[[C4.TA$V#\IGV3C.AI-\:6M4L M?Q3%V;K@Z3(]YAREM*\9C%2RZ`N*;^I.3^59%[28TDKE%3H5L'N!08^$28Y!4=Z2%M`FAA4T"G' MO82)R%$A=%1]B%&V`ZO&\_.MB3,FDDRK@7J]-Z31-+G#0+RX`FZ/UAL9#IZ> M5%^A9<)'18DYR>-<#'I8MX<5IQ7!?DU.*4>"16QD652K(#CR&I>RZEX3EA26BW1=9 M5CSSID!E?3THU8,Z6D0=28D[\,$S0Y/RZ':\EZ&-,QKS+H:<,-[Z(&9E*+B? MS&?-1/N`(RU9D;@=>7X!P:BJJJ$13 M)Z`2VW9XQRF+YO'0/I!MPA=M0L[P9M$NXFU4-4W3N'`HFJ>C5YPA'7/YF6FW MWYGX&_W4?'V@OO=I:O[_OK-L4Q'*LF45=_V4=YU793!V]A`A(_&QNMK#!T:J M8(II+ZLFSJ7S+U63)G%ZWZ=HH<=8''U-?2A*5K]\&(_7^@E+F/:['^ZF\_XK M[NMT=F;B?N*>('C2F9[M8Z,50C,YJO@%/2\OK7NN^<548CGY74[RD8/GJ5S7 M+H^[=:,>\P:\.S);2>8H0=M]$WDY!VWYMIQ"R:EEW_"+@V>)&)T'<5HWRNF\ M7"\+&HQKOH@F_PHP`+7U8Z$-"F5N9'-TJ'-,-(9>I,N,(#T+B`=!%$89@88R@## M#$ULB*A`1!$1`460H(`!HZ%(K(AB(2BH8`]($%!B,(JHJ&1&UDI\>7GOY>7W MQ[W?VF?O<_?9>Y^U+@`D3Q\N+P66`B"9)^`'>CC35X5'T+']``9X@`&F`#!9 MZ:F^0>[!0"0O-Q=ZNL@)_(O>#`%(_+YEZ.E/IX/_3]*L5+X``,A?Q.9L3CI+ MQ/DB3LH4I(KM,R*FQB2*&4:)F2]*4,1R8HY;Y*6??1;94!&; MB)C$#PYT$?%R`'"DN"\XY@L6<+($XD.YI*1F\[EQ\0*Z+DN/;FIMS:![[M(KT*^-PSB-;WA^VO_%+J`&#,BFJSZP];S'X`.K8"('?_#YOF(0`D17UK MO_'%>6CB>8D7"%)MC(TS,S.-N!R6D;B@O^M_.OP-??$](_%VOY>'[LJ)90J3 M!'1QW5@I22E"/CT]E?^IB?\P[$]:G&N1*/6?`#7*"$C=H`+DYSZ`HA`!$GE0W/7?^^:# M#P7BFQ>F.K$X]Y\%_?NN<(GXD,X`9P\QB ML5AYK`'6#NN'96(%V`+L?NPQ[#GL('8<^Q9'Q*GBS'#NN`@<#Y>'*\$AX1202U8G6Q``BE[B)6$$\3KQ"'"6^(\F0]$DNI$B2D+23=(1TGG2/](I, M)FN3'DDN58R M1[)<\J3D#LHERC@50]6A>E$3J$74;ZC]U!E9 M&=EELJ&R6;)5LF=D1V@(39OF14NBE=!.T(9H[YGR;O*)\KOE.^0?*:`4]!4"%#(5#BI<4IA6I"K:*K(4 M"Q5/*-Y7@I7TE0*5UBD=5NI3FE564?903E7>KWQ1>5J%IN*HDJ!2IG)694J5 MHFJORE4M4SVG^HPN2W>B)]$KZ#WT&34E-4\UH5JM6K_:O+J.>HAZGGJK^B,- M@@9#(U:C3*-;8T935=-7,U>S6?.^%EZ+H16OM4^K5VM.6T<[3'N;=H?VI(Z< MCI=.CDZSSD-=LJZ#;IING>YM/8P>0R]1[X#>37U8WT(_7K]*_X8!;&!IP#4X M8#"P%+W4>BEO:=W284.2H9-AAF&SX:@1SJ/U:>MW-I8V M`IL3-K_8&MHFVC;93B[76/MC]D/^*@YL!TJ'-X MXJCAR'9L<)QPTG-*<#KF],+9Q)GOW.8\YV+CLM[EO"OBZN%:Z-KO)N,6XE;I M]MA=W3W.O=E]QL/"8YW'>4^TI[?G;L]A+V4OEE>CU\P*JQ7K5_1XD[R#O"N] MG_CH^_!]NGQAWQ6^>WP?KM1:R5O9X0?\O/SV^#WRU_%/\_\^`!/@'U`5\#30 M-#`WL#>($A05U!3T)M@YN"3X08ANB#"D.U0R-#*T,70NS#6L-&QDE?&J]:NN MARN$<\,[([`1H1$-$;.KW5;O73T>:1%9$#FT1F=-UIJK:Q76)JT]$R49Q8PZ M&8V.#HMNBO[`]&/6,6=CO&*J8V98+JQ]K.=L1W89>XICQRGE3,3:Q9;&3L;9 MQ>V)FXIWB"^/G^:Z<"NY+Q,\$VH2YA+]$H\D+B2%);4FXY*CDT_Q9'B)O)X4 ME92LE(%4@]2"U)$TF[2]:3-\;WY#.I2^)KU30!7]3/4)=85;A:,9]AE5&6\S M0S-/9DEG\;+ZLO6S=V1/Y+CG?+T.M8ZUKCM7+7=S[NAZI_6U&Z`-,1NZ-VIL MS-\XOLECT]'-A,V)FW_(,\DKS7N])6Q+5[YR_J;\L:T>6YL+)`KX!WSWM9?2RPK+7>Z/V7BU?5EZSC[!/N&^DPJ>B<[_F M_EW[/U3&5]ZI5 M'\8-#0H-10T?C_".C!P-/-K3:-78V*345-(,-PN;IXY% M'KOYC>LWG2V&+;6MM-:BX^"X\/BS;Z._'3KA?:+[).-DRW=:WU6W4=H*VZ'V M[/:9COB.D<[PSH%3*TYU=]EVM7UO]/V1TVJGJ\[(GBDY2SB;?W;A7,ZYV?.I MYZ\+UVY['[Y8J]3[[DK=E=.7[6Y>NH:XUK' M=N;70/+!\X..@Q>N.5ZZ_)MK]O7[ZR\ M,S`4,G1W.')XY"[[[N2]I'LO[V?$CJ4?ECY4>U_VH]V/KB.7( MF5'7T;XG04\>C+'&GO^4_M.'\?RGY*?E$ZH3C9-FDZ>GW*=N/EO];/QYZO/Y MZ8*?I7^N?J'[XKM?''_IFUDU,_Z2_W+AU^)7\J^.O%[VNGO6?_;QF^0W\W.% M;^7?'GW'>-?[/NS]Q'SF!^R'BH]Z'[L^>7]ZN)"\L/";``,`]X3S^PH-"F5N M9'-T%LM M-34X("TS,#<@,C`P,"`Q,#(V72]!7!E M+T9O;G1$97-C%LM-38X("TS,#<@,C`P,"`Q,#`W72]!7!E+T9O;G1$97-C'1'4W1A=&4O4T$@9F%L`5$"KP"7`5$@B(44B89?*20"?P<%O4AE&4!?RA% M*\*!F(VAH50%B&;8'#Y2:Q2IP=-Y3F@*IRC^^%C,T:J$KL55Y6S3+YVUZ-K; MA87]W<_M$TEQW6[L1=4-'1TDRZ?.BK)WNY777;=M+R:;:KOU&CEH1J,AQRT: M"V?HJS+HIOSTQ1]ZL7O< MWB;#S1KD?FG6;.K&EC\JM&U:KW?.BE/7=I.JV[N7NWZ0B+*K&E'N[K8K5W?] MWNVL>[VPO!SCF>"9>HM)U#]MN]MO8VPG[6]Q6O\2B]8]5AMQ)RO.W?(N1)[8A];9Y]`9 MBFUZ[^)(K[RRK]RKW8]3>_&_EOE(L?XPN=\?C?[#EPX='5.X8F*RO]1S2O`R MFK\OX_ZFKTF;YP_0<]`<'['#M1RA51%:':%-#]"J]PW)(A+D$5IS<#%S*F*& M$C7!F!'*F!E*%7$^J6/$:8PXBQ'G,>*8`7!E+U!A9V5S+TMI9'-; M-#@@,"!273X^#65N9&]B:@TU(#`@;V)J#3P\+U-U8G1Y<&4O6$U,+TQE;F=T M:"`T,#$U+U1Y<&4O365T861A=&$^/G-TFMC.60B/SX*/'@Z>&UP M;65T82!X;6QN#IX;7!T:STB061O8F4@ M6$U0($-O&UL;G,Z<&1F>#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]P9&9X+S$N,R\B/@H@ M("`@("`@("`\<&1F>#I#;VUP86YY/E-E8W5R:71I97,@86YD($5X:&%N9V4@ M0V]M;6ES#I#;VUP86YY/@H@("`@("`@("`\<&1F>#I3;W5R M8V5-;V1I9FEE9#Y$.C(P,#DP,3$R,C`T-S,T/"]P9&9X.E-O=7)C94UO9&EF M:65D/@H@("`@("`\+W)D9CI$97-C&UL;G,Z>&%P/2)H M='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C`O(CX*("`@("`@("`@/'AA<#I# M&%P M.D-R96%T;W)4;V]L/@H@("`@("`@("`\>&%P.DUO9&EF>41A=&4^,C`P.2TP M,2TQ,E0Q-3HT-SHT.2TP-3HP,#PO>&%P.DUO9&EF>41A=&4^"B`@("`@("`@ M(#QX87`Z0W)E871E1&%T93XR,#`Y+3`Q+3$R5#$U.C0W.C0W+3`U.C`P/"]X M87`Z0W)E871E1&%T93X*("`@("`@("`@/'AA<#I-971A9&%T841A=&4^,C`P M.2TP,2TQ,E0Q-3HT-SHT.2TP-3HP,#PO>&%P.DUE=&%D871A1&%T93X*("`@ M("`@/"]R9&8Z1&5S8W)I<'1I;VX^"B`@("`@(#QR9&8Z1&5S8W)I<'1I;VX@ M&%P34TZ&%P34TZ"UD969A=6QT(B\^"B`@("`@("`@ M("`@(#PO2A396-U&AA;F=E($-O M;6UI')E9@T*,"`T-@T*,#`P,#`P,#`P,"`V-34S-2!F M#0HP,#`P,#`V.3')E9@T*,3$V#0HE)45/ #1@T* ` end -----END PRIVACY-ENHANCED MESSAGE-----